» Articles » PMID: 35563252

The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas

Abstract

Corticotroph cells give rise to aggressive and rare pituitary neoplasms comprising ACTH-producing adenomas resulting in Cushing disease (CD), clinically silent ACTH adenomas (SCA), Crooke cell adenomas (CCA) and ACTH-producing carcinomas (CA). The molecular pathogenesis of these tumors is still poorly understood. To better understand the genomic landscape of all the lesions of the corticotroph lineage, we sequenced the whole exome of three SCA, one CCA, four ACTH-secreting PA causing CD, one corticotrophinoma occurring in a CD patient who developed Nelson syndrome after adrenalectomy and one patient with an ACTH-producing CA. The ACTH-producing CA was the lesion with the highest number of single nucleotide variants (SNV) in genes such as , and . The variant was found only in the ACTH-CA and in the corticotrophinoma occurring in a patient with Nelson syndrome. In CCA, SNV in and SNV were present. and SNVs were present in all three SCA, whereas in two of these tumors SNV in and were found. None of the analyzed tumors showed SNV in or . The amplification of 17q12 was found in all tumors, except for the ACTH-producing carcinoma. The four clinically functioning ACTH adenomas and the ACTH-CA shared the amplification of 10q11.22 and showed more copy-number variation (CNV) gains and single-nucleotide variations than the nonfunctioning tumors.

Citing Articles

Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Jotanovic J, Boldt H, Burton M, Andersen M, Bengtsson D, Bontell T Acta Neuropathol. 2024; 148(1):68.

PMID: 39580368 PMC: 11585505. DOI: 10.1007/s00401-024-02836-5.


The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors.

Casar-Borota O, Burman P, Lopes M Brain Pathol. 2024; 35(1):e13302.

PMID: 39218431 PMC: 11669403. DOI: 10.1111/bpa.13302.


Longitudinal multiomics analysis of aggressive pituitary neuroendocrine tumors: comparing primary and recurrent tumors from the same patient, reveals genomic stability and heterogeneous transcriptomic profiles with alterations in metabolic pathways.

Taniguchi-Ponciano K, Hinojosa-Alvarez S, Hernandez-Perez J, Chavez-Santoscoy R, Remba-Shapiro I, Guinto G Acta Neuropathol Commun. 2024; 12(1):142.

PMID: 39217365 PMC: 11365143. DOI: 10.1186/s40478-024-01796-x.


Targeted analysis of Ubiquitin-Specific Peptidase (USP8) in a population of Iranian people with Cushing's disease and a systematic review of the literature.

Hashemi-Madani N, Cheraghi S, Emami Z, Mehrjardi A, Kaynama M, Khamseh M BMC Endocr Disord. 2024; 24(1):86.

PMID: 38862897 PMC: 11165846. DOI: 10.1186/s12902-024-01619-z.


Association between Intracellular Calcium Signaling and Tumor Recurrence in Human Non-Functioning Pituitary Adenomas.

Santiago-Andres Y, Aquiles A, Taniguchi-Ponciano K, Salame L, Guinto G, Mercado M Int J Mol Sci. 2024; 25(7).

PMID: 38612778 PMC: 11011867. DOI: 10.3390/ijms25073968.


References
1.
Wanichi I, Mariani B, Frassetto F, Siqueira S, Musolino N, Cunha-Neto M . Cushing's disease due to somatic USP8 mutations: a systematic review and meta-analysis. Pituitary. 2019; 22(4):435-442. DOI: 10.1007/s11102-019-00973-9. View

2.
Yagnik G, Jahangiri A, Chen R, Wagner J, Aghi M . Role of a p53 polymorphism in the development of nonfunctional pituitary adenomas. Mol Cell Endocrinol. 2017; 446:81-90. PMC: 5553295. DOI: 10.1016/j.mce.2017.02.017. View

3.
Mamidi T, Wu J, Hicks C . Integrating germline and somatic variation information using genomic data for the discovery of biomarkers in prostate cancer. BMC Cancer. 2019; 19(1):229. PMC: 6417124. DOI: 10.1186/s12885-019-5440-8. View

4.
Perez-Rivas L, Theodoropoulou M, Ferrau F, Nusser C, Kawaguchi K, Stratakis C . The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease. J Clin Endocrinol Metab. 2015; 100(7):E997-1004. PMC: 4490309. DOI: 10.1210/jc.2015-1453. View

5.
Melmed S . Pituitary-Tumor Endocrinopathies. N Engl J Med. 2020; 382(10):937-950. DOI: 10.1056/NEJMra1810772. View